Jump to content

ROSEN, A LEADING LAW FIRM, Reminds Nektar Therapeutics Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm


In The News

Recommended Posts

Archived

This topic is now archived and is closed to further replies.



×
×
  • Create New...